<?xml version="1.0" encoding="UTF-8"?>
<p id="par0110">We lack a clear understanding of the natural history of SARS-CoV-2 infection in pregnant women and the risk of in utero transmission. Prospective cohort studies should be able to answer the following important questions:
 <list list-type="simple" id="lis0005">
  <list-item id="lsti0005">
   <label>-</label>
   <p id="par0115">What is the impact of SARS CoV-2 on maternal and pregnancy outcomes according to the period of infection in pregnancy, the severity and management, including therapies?</p>
  </list-item>
  <list-item id="lsti0010">
   <label>-</label>
   <p id="par0120">What are the proportions with viral replication and its duration in the nasopharyngeal tract, intestine and maternal blood?</p>
  </list-item>
  <list-item id="lsti0015">
   <label>-</label>
   <p id="par0125">What are the risks of mother-to-child during the pregnancy, during labor and vaginal delivery and postnatally, in children who are not separated from the mother, as is common practice in most settings outside of China.</p>
  </list-item>
 </list>
</p>
